Clinical Trial Update: Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. [Phase 3]

View source ↗

Summary

Phase 3 trial update on using aspirin to prevent preeclampsia in recipients of donated oocytes; study status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Pre-Eclampsia | Phase 3 | Status: TERMINATED